Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US House Expected To Vote On Device-Tax Bill Tuesday

Executive Summary

The House is expected to vote on a standalone bill to repeal the medical device tax July 24. Industry groups are hoping for a quick and easy passage of the bill so it doesn't become entangled in other political battles, such as the upcoming debate on a new Supreme Court justice.

You may also be interested in...



Medtech Groups To Blitz Congress Before Expected House Device Tax Vote

After Minnesota Congressman Erik Paulsen seemed to confirm plans for a floor vote on the medical device excise tax repeal before August, medical device lobby groups say they are rallying to get the deal done before it gets pushed off the agenda by the upcoming US Supreme Court nomination process.

Under New Rule, Sponsors Are Not Required To Submit Multiple Paper Copies To FDA

The US FDA has finalized a new rule that updates a slew of agency regulations so sponsors no longer have to submit multiple paper copies of premarket submission applications. The agency says the rule could save companies millions of dollars.

FDA Gives Sponsors A New Tool To Prove MRI-Compatibility

The US FDA has qualified a new modeling tool that could give sponsors more assurance that their products meet the agency’s expectations for MRI-compatibility.

Topics

UsernamePublicRestriction

Register

MT123021

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel